PDI is a leading, New-Jersey based healthcare commercialization company providing go-to-market  strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States. PDI’s subsidiary, Interpace Diagnostics, is focused on developing and commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for better patient diagnosis and management.

CDPR conducted a full-service public relations plan, working jointly with its investor relations agency and pharmaceutical public relations group designed to increase awareness of PDI in the healthcare community as a leader in CSO (Contract Sales Organization), designed to establish CEO, Nancy Lurker as an incisive thought leader, attract more customers to the company and site, and create greater awareness of PDI and Interpace Diagnostics in the investment community.

Work included product launches consisting of the announcement of a new rep communications computer technology platform, and game changing molecular diagnostic test. Its PR Plan included of the composition and distribution of press releases, and correspondence to internal and external constituents to prepare the eventual sale of the company as part of a separate plan.